Elon Musk’s brain-implant company Neuralink on Thursday, May 25, said it had received the approval of the US Food and Drug Administration to launch a first-in-human clinical study. | Reuters
FILE PHOTO: Neuralink logo and Elon Musk photo are seen in this illustration taken on December 19, 2022. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo
Elon Musk’s brain-implant company Neuralink on Thursday, May 25, said it had received the approval of the US Food and Drug Administration to launch a first-in-human clinical study. Several times since 2019, billionaire Elon Musk has predicted his brain-chip company would soon secure FDA approval for human trials. But the company’s application was rejected in early 2022, and the company was working through the agency’s concerns over the safety of the experimental implant.